4418
Suberoylanilide hydroxamic acid ( SAHA ) has been approved as a drug to treat cutaneous T cell lymphoma , and the combination of HDACi and other agents have been actively tested in many clinical trials .
 Anatomy: cutaneous T cell lymphoma
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: Anatomy 
Text: {0} 
 Entities: cutaneous T cell lymphoma 
Answer:
 Anatomy: cutaneous T cell lymphoma